Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dennis Orgill

Plastic and Reconstructive Surgery Boston, MA Medical Doctor

NPI 1851479018 CMS profile 311793

75 Francis Street, Brigham And Womens Hospital Division Of Plastic Surgery, Boston, MA 02115

Open in the dashboard

General payments

$86,767

86 records reported · program years 2019–2025

Research payments

$99,693

Paid to them · 27 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$317,499 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Dennis Orgill of Boston, MA is reported in the CMS Open Payments database as having received $86,767 across 86 general payments and $99,693 in research payments paid to them. Separately, studies naming them as principal investigator received $317,499 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $14,797 14
2024 General $1,595 3
2023 General $5,505 9
2022 General $20,838 18
2021 General $2,900 3
2021 Research $11,600 5
2020 General $13,597 10
2020 Research $58,500 14
2019 General $27,534 29
2019 Research $29,593 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dennis Orgill
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Dennis Orgill were reported at $14,797. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Dennis Orgill Plastic and Reconstructive Surgery median Middle half National median
2019 $27,534 $335 $121–$1,264 $163
2020 $13,597 $162 $57–$417 $114
2021 $2,900 $245 $89–$735 $132
2022 $20,838 $325 $120–$932 $149
2023 $5,505 $343 $129–$999 $160
2024 $1,595 $390 $141–$1,085 $164
2025 $14,797 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Integra LifeSciences Corporation $30,274 36 payments
  2. Urgo Medical North America, LLC $16,482 16 payments
  3. Smith+Nephew, Inc. $14,278 12 payments
  4. Medline Industries, Inc. $10,467 3 payments
  5. ConvaTec Inc. $3,713 1 payment
  6. Musculoskeletal Transplant Foundation Inc. $3,235 7 payments
  7. KCI USA, Inc $3,088 3 payments
  8. Geistlich Pharma, North America, Inc. $2,750 1 payment
  9. Mallinckrodt Hospital Products Inc. $1,800 2 payments
  10. TEI Biosciences Inc $394 2 payments
  11. Other $286 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $51,580 29 payments
  2. Travel and Lodging $16,580 20 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $15,388 10 payments
  4. Food and Beverage $2,728 26 payments
  5. Long term medical supply or device loan $491 1 payment
Products named General payments · program years 2019–2025
  1. FLOWABLE $21,659 27 payments
  2. BILAYER WOUND MATRIX (BWM) $21,659 27 payments
  3. INTEGRA WOUND MATRIX (IWM) $21,181 21 payments
  4. IDRT $21,181 21 payments
  5. VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP $16,482 16 payments
  6. RENASYS Touch $13,661 10 payments
  7. Dermatology and Wound Care $10,467 3 payments
  8. AQUACEL AG $3,713 1 payment
  9. SURGIMEND $3,709 4 payments
  10. ADVANCED WOUND CARE $3,550 2 payments
  11. Other $18,835 36 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. PolarityTE, Inc. $97,193 26 payments
  2. Integra LifeSciences Corporation $2,500 1 payment

Billing to Medicare

Part B · data year 2024 · 102 billing codes

Paid by Medicare

$99,115

Medicare's payments for the services billed

Medicare patients

214

Average age 68

Services billed

646

123 women, 91 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 70%
Arthritis 55%
Depression 35%
Ischemic heart disease 32%
Chronic kidney disease 29%
Cancer 29%
Osteoporosis 28%
Atrial fibrillation 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

113 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record